Gregor Diagnostics, a molecular diagnostics company developing an at-home screening test for prostate cancer, closed a $900,000 round of seed financing, the company announced recently. According to a release, the…

Gregor Diagnostics announced today a licensing agreement for intellectual property with the Wisconsin Alumni Research Foundation. According to a release, the molecular diagnostics company will have exclusive rights to biomarkers that…